Terms: = Brain cancer AND MEN1, ENSG00000133895, 4221 AND Diagnosis
73 results:
1. Clinical Factors Predicting Multiple Endocrine Neoplasia Type 1 and Type 4 in Patients with Neuroendocrine Tumors.
Faggiano A; Fazzalari B; Mikovic N; Russo F; Zamponi V; Mazzilli R; Guarnieri V; Piane M; Visco V; Petrucci S
Genes (Basel); 2023 Sep; 14(9):. PubMed ID: 37761922
[TBL] [Abstract] [Full Text] [Related]
2. The clinical and therapeutic profiles of prolactinomas associated with germline pathogenic variants in the
Vroonen L; Beckers A; Camby S; Cuny T; Beckers P; Jaffrain-Rea ML; Cogne M; Naves L; Ferriere A; Romanet P; Elenkova A; Karhu A; Brue T; Barlier A; Pétrossians P; Daly AF
Front Endocrinol (Lausanne); 2023; 14():1242588. PubMed ID: 37711900
[TBL] [Abstract] [Full Text] [Related]
3. Neuroendocrine tumors in a patient with multiple endocrine neoplasia type 1 syndrome: A case report and review of the literature.
Deng J; Liao X; Cao H
Medicine (Baltimore); 2023 Jul; 102(29):e34350. PubMed ID: 37478229
[TBL] [Abstract] [Full Text] [Related]
4. brain and/or Spinal Cord Tumors Accompanied with Other Diseases or Syndromes.
Capitanio JF; Mortini P
Adv Exp Med Biol; 2023; 1405():645-672. PubMed ID: 37452957
[TBL] [Abstract] [Full Text] [Related]
5. Traits of Patients With Pituitary Tumors in Multiple Endocrine Neoplasia Type 1 and Comparing Different Mutation Status.
Lin KY; Kuo YT; Cheng MF; Chen PL; Wang HP; Cheng TY; Chang CH; Kao HF; Yang SH; Li HY; Lin CH; Chou YT; Chung AK; Wu WC; Lu JY; Wang CY; Hsih WH; Wen CY; Yang WS; Shih SR
J Clin Endocrinol Metab; 2023 Nov; 108(12):e1532-e1541. PubMed ID: 37390813
[TBL] [Abstract] [Full Text] [Related]
6. Pituitary Tumorigenesis-Implications for Management.
Vamvoukaki R; Chrysoulaki M; Betsi G; Xekouki P
Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109772
[TBL] [Abstract] [Full Text] [Related]
7. Clinical and molecular features of four Brazilian families with multiple endocrine neoplasia type 1.
Miranda ISM; Valadares LP; Barra GB; Mesquita PG; de Santana LB; de Castro LF; Rita THS; Naves LA
Front Endocrinol (Lausanne); 2023; 14():1117873. PubMed ID: 36967793
[TBL] [Abstract] [Full Text] [Related]
8.
Trofimiuk-Müldner M; Domagała B; Sokołowski G; Skalniak A; Hubalewska-Dydejczyk A
Front Endocrinol (Lausanne); 2023; 14():1098367. PubMed ID: 36843582
[TBL] [Abstract] [Full Text] [Related]
9. Rare clinical manifestation of multiple endocrine neoplasia type 1.
Petriczko E; Marcinkiewicz K; Prokurat A; Sagan L; Malkowski B; Biczysko-Mokosa A; Horodnicka-Jozwa A; Andrysiak-Mamos E; Syrenicz A; Kostrzeba E; Walczak M
Neuro Endocrinol Lett; 2022 Nov; 43(4):199-207. PubMed ID: 36528881
[TBL] [Abstract] [Full Text] [Related]
10. Germline CDKN1B variant type and site are associated with phenotype in MEN4.
Halperin R; Arnon L; Nasirov S; Friedensohn L; Gershinsky M; Telerman A; Friedman E; Bernstein-Molho R; Tirosh A
Endocr Relat Cancer; 2023 Jan; 30(1):. PubMed ID: 36256846
[TBL] [Abstract] [Full Text] [Related]
11. Long delay in diagnosis of a case with men1 due to concomitant presence of AIMAH with insulinoma: a case report and literature review.
Chavoshi V; Tamehri Zadeh SS; Khalili S; Rabbani A; Matini SAH; Mohsenifar Z; Hadaegh F
BMC Endocr Disord; 2022 Apr; 22(1):108. PubMed ID: 35448982
[TBL] [Abstract] [Full Text] [Related]
12. Molecular genetic testing in the management of pituitary disease.
Coopmans EC; Korbonits M
Clin Endocrinol (Oxf); 2022 Oct; 97(4):424-435. PubMed ID: 35349723
[TBL] [Abstract] [Full Text] [Related]
13. Update on the clinical management of multiple endocrine neoplasia type 1.
Pieterman CRC; Valk GD
Clin Endocrinol (Oxf); 2022 Oct; 97(4):409-423. PubMed ID: 35319130
[TBL] [Abstract] [Full Text] [Related]
14. The Importance of Periodical Screening for Primary Hyperparathyroidism in a Pituitary Tumor Cohort in Searching Patients With men1 and Its Genetic Profile.
Damianse SSP; Nascimento GC; Rocha VCC; Nascimento AGPAC; Gaido NC; Azulay RSS; Dos Santos WC; Rodrigues VP; Quidute ARP; Magalhães M; Dos S Faria M
Endocr Pract; 2022 May; 28(5):509-514. PubMed ID: 35247589
[TBL] [Abstract] [Full Text] [Related]
15. Clinical and genetic characteristics in patients under 30 years with sporadic pituitary adenomas.
Martínez de LaPiscina I; Portillo Najera N; Rica I; Gaztambide S; Webb SM; Santos A; Moure MD; Paja Fano M; Hernandez MI; Chueca-Guindelain MJ; Hernández-Ramírez LC; Soto A; Valdés N; Castaño L
Eur J Endocrinol; 2021 Aug; 185(4):485-496. PubMed ID: 34313605
[TBL] [Abstract] [Full Text] [Related]
16. Low risk for all-cause mortality among patients with lung neuroendocrine tumors co-diagnosed with pituitary adenomas.
Peltz-Sinvani N; Percik R; Uri I; Kfir SK; Tirosh A; Tirosh A
Endocrine; 2021 Sep; 73(3):745-751. PubMed ID: 33982234
[TBL] [Abstract] [Full Text] [Related]
17. New therapies for patients with multiple endocrine neoplasia type 1.
Geslot A; Vialon M; Caron P; Grunenwald S; Vezzosi D
Ann Endocrinol (Paris); 2021 Apr; 82(2):112-120. PubMed ID: 33839123
[TBL] [Abstract] [Full Text] [Related]
18. Multiple endocrine neoplasia type 1 with refractory hypoglycemia and lung and liver metastases: a case report.
Wang Y; Zhang H
J Int Med Res; 2021 Jan; 49(1):300060520961682. PubMed ID: 33435778
[TBL] [Abstract] [Full Text] [Related]
19. Prolactinoma in childhood and adolescence-Tumour size at presentation predicts management strategy: Single centre series and a systematic review and meta-analysis.
Arya VB; Aylwin SJB; Hulse T; Ajzensztejn M; Kalitsi J; Kalogirou N; Bodi I; Thomas N; Hampton T; Kapoor RR; Buchanan CR
Clin Endocrinol (Oxf); 2021 Mar; 94(3):413-423. PubMed ID: 33340135
[TBL] [Abstract] [Full Text] [Related]
20. Update on the Genetics of Pituitary Tumors.
Barry S; Korbonits M
Endocrinol Metab Clin North Am; 2020 Sep; 49(3):433-452. PubMed ID: 32741481
[TBL] [Abstract] [Full Text] [Related]
[Next]
